Xenon Pharmaceuticals Inc. (XENE)
NASDAQ: XENE · Real-Time Price · USD
32.40
+0.20 (0.62%)
Jun 27, 2025, 4:00 PM - Market closed
Xenon Pharmaceuticals Employees
As of December 31, 2024, Xenon Pharmaceuticals had 327 total employees, including 316 full-time and 11 part-time employees. The number of employees increased by 68 or 26.25% compared to the previous year.
Employees
327
Change (1Y)
68
Growth (1Y)
26.25%
Revenue / Employee
$22,936
Profits / Employee
-$768,948
Market Cap
2.49B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
XENE News
- 17 hours ago - Xenon Joins the Russell 3000® and Russell 2000® Indexes - GlobeNewsWire
- 1 day ago - Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 days ago - Xenon Announces Appointment of Darren Cline as Chief Commercial Officer - GlobeNewsWire
- 24 days ago - Xenon to Present at the Goldman Sachs 46th Annual Global Healthcare Conference - GlobeNewsWire
- 6 weeks ago - Xenon MRI Featured Prominently at ATS 2025 Across Broad Clinical Spectrum - GlobeNewsWire
- 6 weeks ago - Xenon to Present at the 2025 RBC Capital Markets Global Healthcare Conference - GlobeNewsWire
- 6 weeks ago - Xenon Pharmaceuticals Inc. (XENE) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Xenon Reports First Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire